Gynaecology services for women who have had a bone marrow transplant.

An observational study investigating the objective and subjective impact of a structured gynaecology service for women who have undergone allogeneic stem cell transplant.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ANZCTR

Registry ID

ACTRN12607000504415

Enrollment

Registered

2007-10-04

Start date

2009-05-08

Completion date

2010-09-28

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Sexuality and fertility concerns confront men and women post allogeneic haematolpoietic stem cell transplant (HSCT). Surviving a transplant is much more likely today due to better supportive care and better medications. Improving the lives of people who have had transplants is increasingly the main focus of ongoing care. Many of the problems that occur after a transplant are related to graft versus host disease (GVHD). GVHD can affect the vagina and is an important post transplant adverse event. This study uses a questionnaire to formally evaluate how a structured gynaecology service for women who have had a transplant assists in the prevention and early treatment of this complication. It will also assess the information needs of women in order that better resources might be made available to women in this area of currently unmet need.

Interventions

Nil interventions. It is a questionnaire based study only. The questionnaire asks questions about the information people received about fertility, sexuality and vaginal Graft versus Host Disease (GVHD). It also questions whether women had problems with these issues and whether these problems were effectively resolved. There is only one questionnaire for participants to complete. It will be posted out to eligible women (women who are at least 6 months post transplant). This will take partici

Eligibility

Sex/Gender

All

Age

16 Years to -2147483648 No limit

Healthy volunteers

Inclusion criteria

Women over 16 years of age who have had an allogeneic stem cell transplant greater than six months ago and are able to give written informed consent.

Exclusion criteria

Male. Under 16 years of age. Not able to sign written informed consent.

Outcome results